Kees Recourt: 'InnovationQuarter is proud to invest in Pan Cancer T, contributing to the development of state-of-the-art cell therapies to combat hard-to-treat cancers.'
Rachel Abbott: 'This financing round enables us to advance our lead product toward the clinic, offering new hope for patients with triple-negative breast cancer.'
Collection
[
|
...
]